Proactive - Interviews for investors

Immunic CEO on strong Q2 progress with vidofludimus calcium trials for MS

08 Aug 2025

Audio

Description

Immunic Inc (NASDAQ:IMUX) CEO Dr Daniel Vitt talked with Proactive's Stephen Gunnion about the company’s second-quarter highlights, with a particular focus on clinical progress in its multiple sclerosis (MS) programs. The headline development was the promising results from the Phase 2 CALLIPER trial of vidofludimus calcium, Immunic’s lead asset in progressive MS. Vitt noted a 24% reduction in disability progression across the full study population, with over 30% reduction seen in patients with primary progressive MS. “That basically confirms the mode of action of the drug,” Vitt said, underlining its potential to slow disease progression. Vitt also addressed the completion of enrollment in the Phase 3 ENSURE trials, which are testing vidofludimus calcium in relapsing MS. These two twin studies now include 2,200 patients in total, with data expected by the end of next year. Further support came from long-term results in the EMPhASIS study, testing vidofludimus calcium in relapsing-remitting MS, where more than 90% of patients remained free of disability progression after nearly three years of treatment. Vitt highlighted the low discontinuation rates and long-term adherence as additional positive indicators. Finally, he commented on the company's strengthened financial position, citing recent capital raises as critical to progressing both Phase 3 trials. For more insightful updates from biotech leaders, visit Proactive’s YouTube channel. Don’t forget to like this video, subscribe, and enable notifications so you never miss a story. #ImmunicInc #MultipleSclerosis #VidofludimusCalcium #MSResearch #CALLIPERStudy #ENSURETrial #Neuroprotection #BiotechNews #PharmaUpdates #ClinicalTrials

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes

🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Other recent transcribed episodes

Transcribed and ready to explore now

13:00H | 21 DIC 2025 | Fin de Semana

01 Jan 1970

Fin de Semana

10:00H | 21 DIC 2025 | Fin de Semana

01 Jan 1970

Fin de Semana

12:00H | 20 DIC 2025 | Fin de Semana

01 Jan 1970

Fin de Semana

2ª PARTE | 06 ENE 2026 | EL PARTIDAZO DE COPE

01 Jan 1970

El Partidazo de COPE

3ª PARTE | 22 ENE 2026 | EL PARTIDAZO DE COPE

01 Jan 1970

El Partidazo de COPE

3ª PARTE | 04 MAR 2026 | EL PARTIDAZO DE COPE

01 Jan 1970

El Partidazo de COPE

Comments

There are no comments yet.

Please log in to write the first comment.

Report any issue

Proactive - Interviews for investors

Immunic CEO on strong Q2 progress with vidofludimus calcium trials for MS

This episode hasn't been transcribed yet

Other recent transcribed episodes

13:00H | 21 DIC 2025 | Fin de Semana

10:00H | 21 DIC 2025 | Fin de Semana

12:00H | 20 DIC 2025 | Fin de Semana

2ª PARTE | 06 ENE 2026 | EL PARTIDAZO DE COPE

3ª PARTE | 22 ENE 2026 | EL PARTIDAZO DE COPE

3ª PARTE | 04 MAR 2026 | EL PARTIDAZO DE COPE

Sign in to Audioscrape

Share this moment